Clinical Trials Logo
  1. Home
  2. TBI (Traumatic Brain Injury)
  3. NCT05807503

Evaluation of the Effect of Neuroprotective Drug on Treatment Result in Patients After Traumatic Brain Injury

TBI (Traumatic Brain Injury) Clinical Trial

Official title:
Evaluation of the Effect of Early Administered Neuroprotective Drug on Treatment Result in Patients After Traumatic Brain Injury - PILOT Trial

Clinical Trial Summary

Traumatic Brain Injury TBI is one of the most common causes of death and recovery failure worldwide. Each element of treatment, starting from possible surgical treatment, patient monitoring and neuroprotective treatment, can be important in the overall outcome of patients' treatment. More and more elements of treatment are discussed in the literature in the multimodal approach to the patient with a trauma to the central nervous system. Cerebrolysin is a drug with a proven beneficial effect on the prognosis of patients with TBI. In our trial we stated the hypothesis that Cerebrolysin in combination with multimodal monitoring and surgical craniotomy is beneficial for the patients. In retrospective analysis we divided the patients into two groups : with and without cerebrolysin. We also analyzed how cerebrolysin influences the treatment results with the combination with additional neuromonitoring of both invasive intracranial pressure (ICP) measurement and non-invasive saturation in the jugular vein, nirs, ultrasound of the optic nerve diameter. We also analyzed if there is any change in the results of treatment after combining Cerebrolysin with another neuroprotective drug : amantadine. We also analyzed the influence of craniotomy combined with cerebrolysin treatment. In an observational study, we collected information on 56 patients.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05807503
Study type Observational
Source Pomeranian Medical University Szczecin
Contact
Status Completed
Phase
Start date February 1, 2020
Completion date November 30, 2022
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT04526639 - VR Cognitive Rehabiliation for Pediatric TBI N/A
Recruiting NCT05943756 - Evaluation of Well-being Interventions in Adults With TBI N/A
Completed NCT01339702 - The EPIC Project: Impact of Implementing the EMS Traumatic Brain Injury Treatment Guidelines
Completed NCT00760734 - Hyperbaric Oxygen Therapy (HBOT) in Chronic Traumatic Brain Injury (TBI)/Post Concussion Syndrome (PCS) and TBI/Post-Traumatic Stress Disorder (PTSD) Phase 1
Not yet recruiting NCT06024122 - Brain Development in Young Children Following Mild Traumatic Brain Injury - Pilot Study
Completed NCT03896789 - Pediatric Guideline Adherence and Outcomes- Argentina N/A
Completed NCT03225768 - Guided Training for People With Cognitive Impairment N/A
Completed NCT04590911 - Effectiveness of Multimodal Cognitive Rehabilitation for Traumatic Brain Injury Sustained During Older Adulthood N/A
Recruiting NCT04121780 - Growth Hormone Replacement Therapy for Retried Professional Football Players Phase 2
Completed NCT04776304 - Art Therapy qEEG Study for Service Members With a Traumatic Brain Injury and Posttraumatic Stress Symptoms N/A
Completed NCT00409058 - Teen Online Problem Solving (TOPS) - An Online Intervention Following TBI N/A
Completed NCT00205491 - Pharmacological Intervention in Depression After Traumatic Brain Injury Phase 4
Completed NCT03490110 - Brain Markers of Improvements in Cognitive Functioning N/A
Active, not recruiting NCT02525432 - Autologous Stem Cell Study for Adult TBI (Phase 2b) Phase 2
Completed NCT02858544 - Concussion in Motor Vehicle Accidents: The Concussion Identification Index N/A
Completed NCT01728831 - Study of Cerebral Tissue Oxygenation During Transfusion in Traumatic Brain Injury N/A
Recruiting NCT06005194 - InMotion - Telehealth Delivered Exercise Promotion to Treat Major Depression After TBI N/A
Not yet recruiting NCT05340803 - Sedation of Ventilated Traumatic Brain Injury Patients With Midazolam Alone Versus Combination With Dexmedetomidine or Magnesium Sulfate; Monitored by Ultrasonograghic Optic Nerve Sheath Diameter Phase 3
Recruiting NCT06195345 - Individual Cerebral Hemodynamic Oxygenation Relationships (ICHOR 1)
Recruiting NCT04279431 - Follow-up of mTBI Patients Discharged From the ED Using Standard Clinical Triage Including BrainScope One